Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[3H]ketanserin binding in human brain postmortem

D Marazziti1, A Rossi, L Palego

  • 1Istituto di Psichiatria, Università di Pisa, Roma, Italia. dmarazzipsico.med.unipi.it.

Neurochemical Research
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The superstatistical nature and interoccurrence time of atmospheric mercury concentration fluctuations.

Journal of geophysical research. Atmospheres : JGR·2018
Same author

A Novel Panel of Serum Biomarkers for MPM Diagnosis.

Disease markers·2017
Same author

Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome.

Translational psychiatry·2016
Same author

Isolation of an urate-binding protein by affinity chromatography.

Applied biochemistry and biotechnology·2013
Same author

The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury.

Biochemical pharmacology·2013
Same author

Role of translocator protein (18 kDa) in adult separation anxiety and attachment style in patients with depression.

Current molecular medicine·2012
Same journal

Correction to: Dual Antioxidant DH-217 Mitigated Cerebral Ischemia-Reperfusion Injury by Targeting IKKβ/Nrf2/HO-1 Signal Axis.

Neurochemical research·2026
Same journal

Microglia-Dependent BDNF Signaling in the Dentate Gyrus Underlies the Antidepressant Effects of Gardiquimod, a Toll-Like Receptor 7 Agonist, in Chronically Stressed Mice.

Neurochemical research·2026
Same journal

Cryptotanshinone Targets Ferroptosis in Glioma via the EGFR/ROS Signaling Pathway.

Neurochemical research·2026
Same journal

Combined Puerarin and Magnesium Acetyl Taurate Intervention Mitigates Autism-Like Pathology Through Glutamatergic and MAPK Pathway Regulation.

Neurochemical research·2026
Same journal

Long-Term Impact of Early-Life Stress on Hippocampal Apoptotic Gene Expression in BALB/c Mice.

Neurochemical research·2026
Same journal

Minute-Resolution Sampling Reveals Rapid and Stimulus-Specific IL-1β Dynamics During Acute Epileptiform Activity.

Neurochemical research·2026
See all related articles

This study found that the serotonin 2A (5-HT2A) receptor binding sites are uniformly distributed across key human brain regions. This suggests a consistent receptor density in areas like the prefrontal cortex, hippocampus, and striatum.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • The serotonin 2A (5-HT2A) receptor is a key target for various neurological and psychiatric conditions.
  • Understanding the distribution and binding characteristics of 5-HT2A receptors is crucial for developing effective therapeutics.

Purpose of the Study:

  • To compare the binding characteristics of [3H]ketanserin, a selective 5-HT2A receptor antagonist, in distinct human brain regions.
  • To determine the homogeneity and distribution of 5-HT2A receptors in the prefrontal cortex, hippocampus, and striatum.

Main Methods:

  • Post-mortem human brain tissue from prefrontal cortex, hippocampus, and striatum was used.
  • Radioligand binding assays with [3H]ketanserin were performed to assess receptor density and affinity.

Related Experiment Videos

  • Pharmacological profiling was conducted using various competing drugs to confirm receptor specificity.

    • Main Results:

    • A single population of binding sites for [3H]ketanserin was identified in all investigated brain regions.
    • No significant differences in maximum binding capacity (Bmax) or dissociation constant (Kd) were observed across regions.
    • The drug competition profile confirmed that [3H]ketanserin specifically labels the 5-HT2A receptor.

    Conclusions:

    • The 5-HT2A receptor, as characterized by [3H]ketanserin binding, represents a homogenous population of sites.
    • These receptors are equally distributed across human prefronto-cortical, limbic, and extrapyramidal structures.
    • This uniform distribution has implications for understanding the role of 5-HT2A receptors in various brain functions and disorders.